BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2033444)

  • 1. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
    Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
    J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
    Grunberg SM; Weiss MH; Russell CA; Spitz IM; Ahmadi J; Sadun A; Sitruk-Ware R
    Cancer Invest; 2006 Dec; 24(8):727-33. PubMed ID: 17162554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone (RU 486) treatment of meningiomas.
    Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antiprogestational therapy for meningiomas.
    Grunberg SM
    Hum Reprod; 1994 Jun; 9 Suppl 1():202-7. PubMed ID: 7962466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
    Touat M; Lombardi G; Farina P; Kalamarides M; Sanson M
    Acta Neurochir (Wien); 2014 Oct; 156(10):1831-5. PubMed ID: 25078073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
    Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C
    J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients receiving long-term treatment with mifepristone.
    Spitz IM; Grunberg SM; Chabbert-Buffet N; Lindenberg T; Gelber H; Sitruk-Ware R
    Fertil Steril; 2005 Dec; 84(6):1719-26. PubMed ID: 16359971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal manipulation of meningiomas in vitro.
    Olson JJ; Beck DW; Schlechte J; Loh PM
    J Neurosurg; 1986 Jul; 65(1):99-107. PubMed ID: 3712034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
    Olson JJ; Beck DW; Schlechte JA; Loh PM
    J Neurosurg; 1987 Apr; 66(4):584-7. PubMed ID: 3559725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mifepristone in the management of meningiomas: A systematic review of literature.
    Sharma R; Garg K; Katiyar V; Tandon V; Agarwal D; Singh M; Chandra SP; Suri A; Kale SS; Mahapatra AK
    Neurol India; 2019; 67(3):698-705. PubMed ID: 31347538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone: antineoplastic studies.
    Sartor O; Figg WD
    Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for meningiomas.
    Kyritsis AP
    J Neurooncol; 1996 Sep; 29(3):269-72. PubMed ID: 8858533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocrine effects of long-term treatment with mifepristone (RU 486).
    Lamberts SW; Koper JW; de Jong FH
    J Clin Endocrinol Metab; 1991 Jul; 73(1):187-91. PubMed ID: 1646217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large endometrial polyp in a patient on long-term mifepristone therapy.
    Martineau PA; Levental M
    J Ultrasound Med; 2000 Jul; 19(7):487-9. PubMed ID: 10898303
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma.
    Grunberg SM; Weiss MH
    J Neurooncol; 1990 Feb; 8(1):61-5. PubMed ID: 2319292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
    Koide SS
    J Reprod Med; 1998 Jul; 43(7):551-60. PubMed ID: 9693404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.